Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Published Date: 13 Dec 2024

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simpler Screening Criteria Could Catch More Lung Cancers

2.

When a Groundbreaking Cancer Therapy Causes Cancer.

3.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

4.

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

5.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot